Moderna Inc (MRNA)

Date: O: H: L: C: Vol:

Finanzdaten der Moderna Inc-Aktie (MRNA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	62.72%145.00	389.00	678.00	1,016.00	142.00
Cost Of Revenue	90.26%93.00	955.00	452.00	207.00	119.00
	0.31%651.00	649.00	-	-	-
Research and Development	0.31%651.00	649.00	-	-	-
Costs And Expenses	45.98%960.00	1,777.00	1,535.00	1,276.00	1,049.00
Operating Income/Loss	41.28%-815.00	-1,388.00	-857.00	-260.00	-907.00
Income/Loss From Continuing Operations Before Tax	42.50%-767.00	-1,334.00	-799.00	-187.00	-818.00
Income Tax Expense/Benefit	66.67%15.00	9.00	27.00	13.00	7.00
	41.77%-782.00	-1,343.00	-826.00	-200.00	-825.00
Attributable To Parent	41.77%-782.00	-1,343.00	-826.00	-200.00	-825.00
Basic Average Shares	0.76%398.00	395.00	1.00	390.00	388.00
Diluted Average Shares	0.76%398.00	395.00	1.00	390.00	388.00
Basic Earnings Per Share	42.06%-1.97	-3.40	-2.11	-0.51	-2.13
Diluted Earnings Per Share	42.06%-1.97	-3.40	-2.11	-0.51	-2.13